Hoạt tính chống u của tác nhân gây cảm ứng interferon bropirimine được trung gian một phần bởi yếu tố hoại tử khối u α nội sinh

Agah R, Malloy B, Sherrod A, Mazumder A (1988) Successful therapy of natural killer-resistant pulmonary metastases by the synergism of gamma-interferon with tumor necrosis factor and interleukin-2 in mice. Cancer Res 48: 2245 Anthony LS, Stenvenson MM, Skamene E (1984) Enhancement of resistance toListeria monocytogenes infection in mice by pyrimidine analogs. Clin Invest Med 7: 343 Balkwill FR, Lee A, Aldam G, Moodie E, Thomas JA, Tavernier J, Fiers W (1986) Human tumor xenografts treated with recombinant human tumor necrosis factor alone or in combination with interferons. Cancer Res 46: 3990 Borden EC, Balkwill FR (1984) Preclinical and clinical studies of interferons and interferon inducers in breast cancer. Cancer 53: 783 Eggermont AMM, Marquet RL, de Bruin RWF, Weimar W, Jeekel J (1986) Site-specific anti-tumour effects of 2 pyrimidinone compounds in rats. Br J Cancer 54: 337 Eggermont AMM, Marquet RL, de Bruin RWF, Jeekel J (1986) Effects of the interferon-inducer ABPP on colon cancer in rats: importance of tumor load and tumor site. Cancer Immunol Immunother 22: 217 Havell EA (1987) Production of tumor necrosis factor during murine listeriosis. J Immunol 139: 4225 IJzermans JNM, Marquet RL, Bouwman E, de Bruin RWF, van der Meide PH, Jeekel J (1987) Succesful treatment of colon cancer in rats with recombinant interferon gamma. Br J Cancer 56: 795 Inagawa H, Oshima H, Soma G, Mizuno D (1988) TNF induces endogenous TNF in vivo: the basis of EET therapy as a combination of rTNF together with endogenous TNF. J Biol Response Modif 7: 596 Kato M, Kakehi, Soma G, Gatanaga T, Mizuno D (1985) Antitumour therapy by induction of endogenous tumour necrosis factor. Lancet 3: 270 Kratz SS, Kurlander RJ (1988) Characterization of the pattern of inflammatory cell influx and cytokine production during the murine host defense to Listeria monocytogenes. J Immunol 141: 598 Lotzova E, Saqvary CA, Khan A, Stringfellow DA (1984) Stimulation of natural killer cells in two random-bred strains of athymic rats by interferon-inducing pyrimidinone. J Immunol 132: 2566 Marquet RL, Westbroek DL, Jeekel J (1984) Interferon treatment of a transplantable colon adenocarcinoma; importance of tumor site. Int J Cancer 33: 689 Marquet RL, IJzermans JNM, de Bruin RWF, Fiers W, Jeekel J (1987) Anti-tumor activity of mouse tumor necrosis factor (TNF) on colon cancer in rats is promoted by recombinant rat interferon gamma, toxicity is reduced by indomethacin. Int J Cancer 40: 550 Marquet RL, Eggermont AMM, de Bruin RWF, Fiers W, Jeekel J (1988) Combined treatment of colon adenocarcinoma in rats with TNF and the interferon inducer ABPP. J Interferon Res 8: 319 Milas L, Hersh EM, Stringfellow DA, Hunter N (1982) Studies on the antitumor activities of pyrimidinone-interferon inducers. Effect against artificial and spontaneous lung metastases of murine tumors. JNCI 68: 139 Oku T, Imanishi J, Kishida T (1984) Interferon counteracts pyrimidinone-induced hyporeactivity and the combined treatment has antitumor effect in mice. Gann 75: 631 Pfreundschuh MG, Tilman Steinmetz H, Tueschen R, Schenk V, Diehl V, Schaadt M (1989) Phase 1 study of intratumoral application of recombinant human tumor necrosis factor. Eur J Cancer Clin Oncol 25: 379 Reinhold HS (1966) Quantitative evaluation of the radiosensitivity of cells of a transplantable rhabdomyosarcoma in the rat. Eur J Cancer 2: 33 Richard KA, Mortensen RF, Tracey DE (1987) Cytokines involved in the augmentation of murine natural killer activity by pyrimidinones in vivo. J Biol Response Modif 6: 647 Rosenberg SA (1988) Immunotherapy of cancer using interleukin 2: current status and future prospects. Immunol Today 9: 58 Saito M, Ebina T, Koi M, Yamaguchi T, Kawade Y, Isnida N (1982) Induction of interferon-gamma in mouse spleen cells by OK-432, a preparation ofStreptococcus pyogenes. Cell Immunol 68: 187 Saito M, Nanjo M, Aonuma E, Noda T, Nakadate I, Ebina T, Ishida N (1984) Activated macrophages are responsible for the tumor-inhibitory effect in mice receiving intravenous injection of OK-432. Int J Cancer 33: 271 Satoh M, Inagawa H, Shimada Y, Soma G, Oshima H, Mizuno D (1987) Endogenous production of tumor necrosis factor in normal mice and human cancer patients by interferons and other cytokines combined with biological response modifiers of bacterial origin. J Biol Response Modif 6: 512 Scheringa M, Jeekel J, Marquet RL (1989) Anti-tumor effect of recombinant murine TNF-alpha (rMuTNFa) given by continuous infusion as compared to repeated i. v. injections in a rat liver metastasis model. Int J Cancer 43: 905 Sekimoto M, Kokunai I, Shimano T, Kobayshi T, Takeda T, Haruna N, Yamamoto A, Mori T (1988) Production of tumor necrosis factor (TNF) by monocytes from cancer patients and healthy subjects induced by OK-432 in vitro, and its augmentation by human interferon gamma. J Clin Lab Immunol 27: 115 Shah P, van der Meider PH, Borman T, Schroeder N, Bliss JM, Coombes RC (1989) Effect of human recombinant tumour necrosis factor and rat gamma interferon on nitrosomethylurea-induced mammary tumours. Br J Cancer 59: 206 Talmadge JE, Black PL, Tribble H, Pennington R, Bowersox O, Schneider M, Phillips H (1987) Preclinical approaches to the treatment of metastatic disease: therapeutic properties of RH TNF, RM IFN-gamma, and RH IL-2. Drugs Exp Clin Res 8: 3327 Uchida A, Micksche M, Hoshino T (1984) Intrapleural administration of OK432 in cancer patients: augmentation of autologous tumor killing activity of tumor-associated large granular lymphocytes. Cancer Immunol Immunother 18: 5 Watanabe N, Niitsu Y, Yamauchi N, Umeno H, Sone H, Neda H, Urushizaki I (1988) Antitumor synergism between recombinant human tumor necrosis factor and recombinant human interferon-r. J Biol Response Modif 7: 24 Wierenga W, Skulnick HI, Stringfellow DA, Weed SD, Renis HE, Eidson EE (1980) 5-Substituted 2-amino-6-phenyl-4(3H)-pyrimidinones. Antiviral and interferon inducing agents. J Med Chem 23: 237 Winkelhake JL, Stampfl S, Zimmerman RJ (1987) Synergistic effects of combination therapy with human recombinant interleukin-2 and tumor necrosis factor in murine tumor models. Cancer Res 47: 3948 Yamaue H, Katsumi M, Tabuse K, Tabuse Y, Kuribayashi K, Nishihara T, Saito K (1987) Induction of activated natural killer cells from murine spleen cells primed in vivo and subsequently challenged in vitro with the streptococcal preparation OK 432. Cancer Immunol Immunother 25: 169